Cargando…
Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543200/ https://www.ncbi.nlm.nih.gov/pubmed/26301198 http://dx.doi.org/10.4093/dmj.2015.39.4.348 |
| _version_ | 1782386584447877120 |
|---|---|
| author | Lee, Dae Ho |
| author_facet | Lee, Dae Ho |
| author_sort | Lee, Dae Ho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4543200 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45432002015-08-21 Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) Lee, Dae Ho Diabetes Metab J Letter Korean Diabetes Association 2015-08 2015-08-17 /pmc/articles/PMC4543200/ /pubmed/26301198 http://dx.doi.org/10.4093/dmj.2015.39.4.348 Text en Copyright © 2015 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Lee, Dae Ho Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title | Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_full | Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_fullStr | Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_full_unstemmed | Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_short | Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) |
| title_sort | letter: increased risk of hospitalization for heart failure with newly prescribed dipeptidyl peptidase-4 inhibitors and pioglitazone using the korean health insurance claims database (diabetes metab j 2015;39:247-52) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543200/ https://www.ncbi.nlm.nih.gov/pubmed/26301198 http://dx.doi.org/10.4093/dmj.2015.39.4.348 |
| work_keys_str_mv | AT leedaeho letterincreasedriskofhospitalizationforheartfailurewithnewlyprescribeddipeptidylpeptidase4inhibitorsandpioglitazoneusingthekoreanhealthinsuranceclaimsdatabasediabetesmetabj20153924752 |